Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly
Clinical trial NCT00968890 · COMPLETED
Trial details
- NCT number
- NCT00968890
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-12
- Primary completion
- 2010-09-23
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.